Pharmacokinetic Study of a Fixed Dose Combination Nefopam Hydrochloride (30 mg) / Paracetamol (500 mg)

Clinical trial NCT05129137 · COMPLETED

Trial details

NCT number: NCT05129137
Sponsor: Unither Pharmaceuticals, France
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2021-11-29
Primary completion: 2021-12-27
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.